Related by context. Frequent words. (Click for all words.) 67 placebo controlled clinical 65 Phase 1b clinical 65 Phase 2b study 65 relapsed multiple myeloma 64 Phase 2b clinical 64 phase IIa 64 phase IIb 63 randomized Phase III 63 Phase 2a clinical 63 Phase IIb clinical 62 randomized controlled clinical 62 Phase IIa clinical 62 Phase Ib 62 multicenter clinical 62 Phase 2a trial 61 Phase III clinical 61 Azedra 61 Phase IIb trial 61 relapsed refractory multiple myeloma 61 Phase IIa trial 61 pivotal Phase III 61 label dose escalation 61 Phase III randomized 61 placebo controlled randomized 61 prospective randomized controlled 60 glufosfamide 60 Pivotal Trial 60 multicenter 60 Phase Ia 60 Stedivaze 60 Phase 2b 59 Phase III 59 confirmatory Phase III 59 randomized clinical 59 confirmatory Phase 3 59 phase 2a 59 dose cohorts 59 Phase 2b trial 59 Pivotal Phase III 58 diabetic neuropathic pain 58 registrational 58 Phase 1b trial 58 Phase 1a 58 Phase 1b 58 tesmilifene 58 eculizumab 58 multicenter randomized 58 double blinded placebo 58 dose escalation trial 58 Phase III pivotal 58 ponatinib 58 Pivotal Phase 58 multicenter study 58 nab paclitaxel 58 axitinib 58 Allovectin 7 R 58 active comparator 58 LymphoStat B 58 tanespimycin 58 clinical trial 57 plus prednisone 57 rNAPc2 57 mixed dyslipidemia 57 prospective observational 57 Phase 2a 57 multicentre 57 SUTENT 57 TRITON TIMI 57 blinatumomab 57 Phase IIa 57 diabetic macular edema DME 56 lymphoma CTCL 56 ADHF 56 aHUS 56 Phase IIb 56 safety tolerability pharmacokinetics 56 alvimopan 56 MOZOBIL 56 Asentar 56 hypoparathyroidism 56 idiopathic pulmonary fibrosis IPF 56 blind randomized placebo 56 BLA submission 56 refractory Hodgkin lymphoma 56 blind randomized controlled 56 aflibercept 56 HER2 positive metastatic breast 56 HCV protease inhibitor 55 refractory multiple myeloma 55 multicenter randomized double 55 lupus nephritis 55 Ostarine 55 ELND# 55 HGS ETR1 55 Empatic 55 acute ischemic stroke 55 EORTC 55 Phase III clinical trials 55 eltrombopag 55 hormone refractory prostate cancer 55 randomized placebo controlled